EPS · actual vs est
Revenue · actual vs est
Summary
Generated 2026-02-26
Management highlights
• Zero-harm moment: 2025 TRIR 0.033, zero harm days 96%. • Strategy execution: Thrive and expand in sustainable and mission tech, deliver innovation, operational excellence, deploy capital effectively. • Spin update: Preparations progress, targeted distribution in second half 2026, moving Fraser Nash and UK civil nuclear to sustainable tech. • Fourth quarter and full year results: Revenues, adjusted EBITDA, margins, cash flow details.
Segment performance
Sustainable Tech: 2025 was challenging with petrochemicals capex decline, but SDS was resilient. Margins held in first half, pivoted to Global South, LNG, ammonia, etc. Backlog ended 2025 at $4.2B, up 5% y/y. Near-term pipeline ~$5B. Mission Tech: Faced challenges but performed well, revenue held, margins improved. Backlog and options ended at $19.1B, up 15% y/y. Bids total $17B, 80% new business.
Guidance
• 2026 guidance: Revenues $7.9B - $8.36B, adjusted EBITDA $980M - $1.04B, adjusted EPS $3.87 - $4.22, adjusted operating cash flow $560M - $600M. • Transition costs ~$140 - $180M. • STS expected low double-digit growth at 20%+ margins, MTS low single-digit growth at 10%+ margins. • Assumes resolution of protests, material programs in place, modest interest rate improvement, stable forex.
Risks
• Risks related to forward-looking statements, potential actual results differing. • Risks associated with spin-off process, including operational clarity and standalone positioning. • Risks related to award timing, protest activities, and market volatility affecting business performance.
Q&A highlights
Q: Describe pipeline in STS for sizable projects.
A: Book to bill in Q3, Q4 impressive, global opportunity, Mura running well, LNG work ongoing, BRIS performing well.
Q: Drivers of 15% backlog growth in MTS.
A: Wins like HHPC, Chiburi, Space Force and Air Force Awards, international portfolio growth.
Q: Plaquemines contribution and future opportunities.
A: Contribution runs through 2026, focus on organic and inorganic growth in OPEX area.
Q: MTS margin outlook in 2026.
A: Flat sequentially from 2025 run rates, no uplift assumed.
Q: AI impacts on KBR.
A: Disciplined approach to AI use cases, front and back office applications, ERP implementation progress.
Key numbers
Reported versus consensus
Earnings calendar feed
| Metric | Reported | Consensus | Delta | Prior year |
|---|---|---|---|---|
| EPS | $0.99 | $0.95 | +4.2% | — |
| Revenue | $1.89B | $1.91B | -1.1% | — |
Transcript
February 26, 2026Full transcript unavailable for redistribution
The structured summary above covers the available call sections. Full transcript text is not included on this page.
Continue exploring
Prior quarters
This page presents the stored structured earnings-call summary and deterministic earnings calendar values. How this is generated. For informational purposes only; not investment advice.